CLEC1B Antibody
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) CLEC1B Polyclonal antibody
-
Uniprot No.:Q9P126
-
基因名:CLEC1B
-
别名:1810061I13Rik antibody; C type lectin domain family 1 member B antibody; C type lectin like receptor 2 antibody; C-type lectin domain family 1 member B antibody; C-type lectin domain family 1; member B antibody; C-type lectin-like receptor 2 antibody; C-type lectin-like receptor-2 antibody; CLC1B_HUMAN antibody; CLEC 2 antibody; CLEC 2B antibody; CLEC-2 antibody; CLEC1B antibody; CLEC2 antibody; CLEC2B antibody; PRO1384 antibody; QDED721 antibody
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human C-type lectin domain family 1 member B protein (55-229AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:Antigen Affinity Purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
-
产品提供形式:Liquid
-
应用范围:ELISA, IHC
-
推荐稀释比:
Application Recommended Dilution IHC 1:20-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:C-type lectin-like receptor that functions as a platelet receptor for the lymphatic endothelial marker, PDPN. After ligand activation, signals via sequential activation of SRC and SYK tyrosine kinases leading to activation of PLCG2.; (Microbial infection) Acts as a receptor for the platelet-aggregating snake venom protein rhodocytin. Rhodocytin binding leads to tyrosine phosphorylation and this promotes the binding of spleen tyrosine kinase (SYK) and initiation of downstream tyrosine phosphorylation events and activation of PLCG2.; (Microbial infection) Acts as an attachment facto...显示更多
-
基因功能参考文献:
- CLEC-2 may have a role in unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma PMID: 27564117
- CLEC-2 and P2Y12 are required for CpG ODN-induced platelet activation and thrombosis, and might be targeted to prevent adverse events in patients at risk. PMID: 28296036
- Data (including data from studies using cells from knockout mice) suggest that CLEC2/CLEC2R signaling is dependent on thromboxane A2 generation and is potentiated by co-stimulation with different GNAQ agonists. (CLEC2 = C-type lectin CLEC2; CLEC2R = CLEC2 receptor; GNAQ = guanine nucleotide-binding protein G[q] subunit alpha) PMID: 28705934
- CLEC2 prevents expression of PI3K subunits, in a SYK-dependent manner, to suppress the invasive activities of gastric cancer cells. PMID: 26855187
- CLEC-2 regulates Akt and MAPK downstream of PI3K and PKC, leading to phosphorylation and inhibition of GSK3alpha/beta, and enhanced platelet aggregation and secretion. PMID: 25858425
- Data (including data from studies using recombinant proteins) suggest that a diverse range of ligands activate platelets through activation/phosphorylation of CD36/GPVI (glycoprotein VI) and/or CLEC-2 (C-type lectin-like receptor-2). PMID: 25849538
- PI3K and Tec family kinases play a crucial role in the regulation of platelet activation and Syk phosphorylation downstream of the CLEC-2 receptor PMID: 25767114
- fucoidan is a novel CLEC-2 receptor agonist that activates platelets through a SFK-dependent signaling pathway PMID: 23341451
- Dimerization of two phosphorylated CLEC-2 molecules leads to recruitment of the tyrosine kinase Syk via its tandem SH2 domains and initiation of a downstream signaling cascade PMID: 23264619
- A differential proteomic analysis of basal and rhodocytin-activated platelets with the aim of providing novel clues on CLEC-2 signaling regulation. PMID: 23053573
- The glycosylation sites (N120 and N134) are necessary for the surface expression of CLEC-2. PMID: 22740230
- Shedding of CLEC-2 from the cell surface may reflect increased expression of this membrane protein and serve as a marker of disease activity. PMID: 22736279
- CLEC-2 is the first member of the C-type lectin family of receptors identified to stimulate platelet aggregation through a tyrosine kinase-dependent pathway. (Review) PMID: 21714702
- Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac1. PMID: 20154214
- CLEC-2 activates Syk through dimerization. PMID: 20154219
- X-ray diffraction analysis of human CLEC-2 PMID: 16511244
- Framework for understanding the effects of rhodocytin venom binding on CLEC-2 and for understanding the nature of endogenous ligands which will provide a basis for rational design of drugs to block ligand binding. PMID: 17132623
- Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC2, is reported. PMID: 18583525
- It is the novel platelet activation receptor. (review) PMID: 19483399
- CLEC-2 exists as a non-disulfide-linked homodimer which could allow each Syk molecule to interact with two YXXL motifs, one from each CLEC-2 monomer. PMID: 19824697
收起更多
-
亚细胞定位:Membrane; Single-pass type II membrane protein.
-
组织特异性:Expressed preferentially in the liver. Also expressed in immune cells of myeloid origin and on the surface of platelets.
-
数据库链接:
HGNC: 24356
OMIM: 606783
KEGG: hsa:51266
STRING: 9606.ENSP00000298527
UniGene: Hs.409794